Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    • News

  • Monash University Partners with HITIQ to Advance Concussion Science Using Smart Mouthguards
    Monash University Partners with HITIQ to Advance Concussion Science Using Smart Mouthguards
    • News

  • Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion
    Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion
    • News

  • Pivotal Metals Secures $5.4M to Fast-Track Quebec Drill Program
    Pivotal Metals Secures $5.4M to Fast-Track Quebec Drill Program
    • News

  • Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise
    Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise
    • News

  • DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    • News

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

  • Medibank Backs Emyria with Landmark Depression Care Deal
    Medibank Backs Emyria with Landmark Depression Care Deal
    • News

  • NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    • News

  • BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    • News

EZZ Life Science cracks the US supplements market: A game changer or a calculated gamble?

  • In News
  • June 25, 2024
  • Sidra Surmed
EZZ Life Science cracks the US supplements market: A game changer or a calculated gamble?

Imagine getting access to high-quality supplements for brain focus or essential minerals for your family, all with the backing of a brand that’s shaking up the industry. Yes, that’s the kind of  potential impact we are talking about. The US expansion of EZZ Life Science (ASX: EZZ) may be a game-changer for American consumers seeking effective and efficient health solutions. 

Do you recall the Australian life sciences company’s goal of discovering the mysteries of human health? It always felt a touch grandiose, hinting at something more substantial brewing beneath the surface. Now, with their sights set on the US, the world’s biggest health supplement market.

EZZ’s supplements have secured FDA approval for nine of their health products in the FDA’s food category. This grants those products entry into the world’s biggest health supplement market, valued at USD $23.8 billion in 2023.

“We are thrilled to have received FDA approval for a range of our products. This is a monumental achievement for EZZ and a validation of our commitment to excellence in product quality and innovation,” said Glenn Cross, Chairman of EZZ Life Science 

Entering the US market is a pivotal part of our plans for future growth, and we are excited about the opportunities this approval presents. We look forward to bringing our high-quality products to consumers in the United States and continuing to drive value for our shareholders.”

The nine products approved by the FDA selected by the Company due to their success in other markets are: EZZ Brain Focus, EZZ Children’s Eye Health, EZZ Children’s Essential Minerals , EZZ Magnesium Plus, EZZ Aloe Vera Probiotic Capsules, EZZ Liver Detox, EZZ Joint Energy Boost Tablets, EZZ Men’s Performance. EZZ plans to establish its online presence by selling these products online, similar to how they do in other countries. 

When compared to more established brands in the supplements industry, EZZ is a relatively new company. Brand loyalty is a major factor in the saturation of the US market, a roadblock EZZ will need to overcome to be competitive. . 

EZZ’s US expansion could transform the landscape of the health supplement industry. Their scientifically backed formulae and distinct brand image will be interesting to see how they fare in the competitive US market.

Additionally, with their active expansion of the distribution network, EZZ’s revenue continues to climb, with customer receipts of 23.6 million in the March quarter (Q3 FY24), a significant increase of 111% compared to the same period last year. EZZ maintains a strong financial position with a cash balance of 14.5 million at the end of March 2024 and no outstanding debt. Further commercial sales work is being undertaken by EZZ through their active participation in trade shows and influencer marketing strategies. 

  • About
  • Latest Posts
Sidra Surmed
Sidra is a Business Writer with The Sentiment
Latest posts by Sidra Surmed (see all)
  • Interest in captioning tech sees jump in earnings for AI-Media - August 29, 2024
  • Despite construction industry challenges, Duratec delivers earnings growth - August 28, 2024
  • AI-powered road safety solutions pave the way for Acusensus revenue bump - August 27, 2024
  •  
  •  
  •  
  •  
  • asx ezz
  • EZZ
  • ezz life science
  • Glenn Cross
  • health supplements
  • supplements
  • News

Leave a Comment

You must be logged in to post a comment.

1 Comment

  • Shraddha13
    March 26, 2025, 6:20 pm

    Thank you for sharing! To explore further
    https://www.360iresearch.com/library/intelligence/mineral-supplements

    Reply
  • About
  • Latest Posts
Sidra Surmed
Sidra is a Business Writer with The Sentiment
Latest posts by Sidra Surmed (see all)
  • Interest in captioning tech sees jump in earnings for AI-Media - August 29, 2024
  • Despite construction industry challenges, Duratec delivers earnings growth - August 28, 2024
  • AI-powered road safety solutions pave the way for Acusensus revenue bump - August 27, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Sidra Surmed
Sidra is a Business Writer with The Sentiment
Latest posts by Sidra Surmed (see all)
  • Interest in captioning tech sees jump in earnings for AI-Media - August 29, 2024
  • Despite construction industry challenges, Duratec delivers earnings growth - August 28, 2024
  • AI-powered road safety solutions pave the way for Acusensus revenue bump - August 27, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.